← Leaderboards
Kaushik P Patel
University Of Nebraska Medical Center
$11,800,516
Attributed
$13,828,734
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$13,828,734 · 9
By mechanism
P01$6,947,772 · 3
R01$6,526,772 · 5
R56$354,190 · 1
Top collaborators
- Hong Zheng9 shared
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Hong Zheng$2,028,218
- Irving H Zucker$21,983,867
- William G Mayhan$6,775,419
- Hanjun Wang$9,874,791
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingAnimalsNerveRattusMolecularParaventricular NucleusNitric OxideHeart FailureResponseCellsExercisePeripheralChronicGene TransferRelating To Nervous SystemHypothalamic StructureNeuronsNorepinephrineKidneyBaseBrainCell NucleusNitric Oxide SynthaseAngiotensin Ii
Grant awards (39)
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure$478,112
R01 · FY2024 · DK · contact PI
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure$498,034
R01 · FY2023 · DK · contact PI
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure$498,034
R01 · FY2022 · DK · contact PI
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure$510,235
R01 · FY2021 · DK · contact PI
Novel Target Mechanism (Renal Denervation) to Reduce Sodium Retention in Chronic Heart Failure$414,955
R01 · FY2021 · DK · contact PI
Novel Target Mechanism (Renal Denervation) to Reduce Sodium Retention in Chronic Heart Failure$414,955
R01 · FY2020 · DK · contact PI
Novel Target Mechanism (Renal Denervation) to Reduce Sodium Retention in Chronic Heart Failure$414,955
R01 · FY2019 · DK · contact PI
Activation of the PVN in Heart Failure: Role of HIF-1 Alpha and Renal Afferents$379,162
P01 · FY2019 · HL · contact PI
Novel Target Mechanism (Renal Denervation) to Reduce Sodium Retention in Chronic Heart Failure$414,712
R01 · FY2018 · DK · contact PI
Activation of the PVN in Heart Failure: Role of HIF-1 Alpha and Renal Afferents$379,162
P01 · FY2018 · HL · contact PI
Novel Target Mechanism (Renal Denervation) to Reduce Sodium Retention in Chronic Heart Failure$412,444
R01 · FY2017 · DK · contact PI
Activation of the PVN in Heart Failure: Role of HIF-1 Alpha and Renal Afferents$379,162
P01 · FY2017 · HL · contact PI
Activation of the PVN in Heart Failure: Role of HIF-1 Alpha and Renal Afferents$379,162
P01 · FY2016 · HL · contact PI
Activation of the PVN in Heart Failure: Role of HIF-1 Alpha and Renal Afferents$379,162
P01 · FY2015 · HL · contact PI
Role of HIF1-alpha and Renal afferents in Activation of the PVN in Heart Failure$354,190
R56 · FY2014 · HL · contact PI
The Role of Excitatory Input into the PVN on Increased Sympathetic Drive in Heart$405,087
P01 · FY2013 · HL · contact PI
The Role of Excitatory Input into the PVN on Increased Sympathetic Drive in Heart$419,738
P01 · FY2012 · HL · contact PI
Exercise training improves erectile dysfunction in diabetes: role of central mech$316,560
R01 · FY2012 · DK · contact PI
The Role of Excitatory Input into the PVN on Increased Sympathetic Drive in Heart$436,921
P01 · FY2011 · HL · contact PI
Exercise training improves erectile dysfunction in diabetes: role of central mech$316,560
R01 · FY2011 · DK · contact PI
The Role of Excitatory Input into the PVN on Increased Sympathetic Drive in Heart$437,094
P01 · FY2010 · HL · contact PI
The Role of Excitatory Input into the PVN on Increased Sympathetic Drive in Heart$419,737
P01 · FY2010 · HL · contact PI
Exercise training improves erectile dysfunction in diabetes: role of central mech$352,836
R01 · FY2010 · DK · contact PI
The Role of Excitatory Input into the PVN on Increased Sympathetic Drive in Heart$419,737
P01 · FY2009 · HL · contact PI
Exercise training improves erectile dysfunction in diabetes: role of central mech$356,400
R01 · FY2009 · DK · contact PI
FUNCTION OF PVN IN HEART FAILURE: ROLE OF NO AND NMDA$487,568
P01 · FY2008 · HL · contact PI
FUNCTION OF PVN IN HEART FAILURE: ROLE OF NO AND NMDA$482,993
P01 · FY2007 · HL · contact PI
FUNCTION OF PVN IN HEART FAILURE: ROLE OF NO AND NMDA$371,925
P01 · FY2006 · HL · contact PI
FUNCTION OF PVN IN HEART FAILURE: ROLE OF NO AND NMDA$361,088
P01 · FY2005 · HL
FUNCTION OF PVN IN HEART FAILURE: ROLE OF NO AND NMDA$371,951
P01 · FY2004 · HL
ALTERED NITRIC OXIDE MECHANISMS IN PVN DURING DIABETES$216,435
R01 · FY2002 · NS
VOLUME REGULATION IN DIABETES--INTRARENAL MECHANISMS$170,725
R01 · FY2002 · HL
FUNCTION OF THE PVN IN HEART FAILURE--ROLE OF NITRIC OXIDE AND GABA$142,461
P01 · FY2002 · HL
ALTERED NITRIC OXIDE MECHANISMS IN PVN DURING DIABETES$210,132
R01 · FY2001 · NS
VOLUME REGULATION IN DIABETES--INTRARENAL MECHANISMS$165,754
R01 · FY2001 · HL
FUNCTION OF THE PVN IN HEART FAILURE--ROLE OF NITRIC OXIDE AND GABA$142,461
P01 · FY2001 · HL
ALTERED NITRIC OXIDE MECHANISMS IN PVN DURING DIABETES$204,010
R01 · FY2000 · NS
VOLUME REGULATION IN DIABETES--INTRARENAL MECHANISMS$160,924
R01 · FY2000 · HL
FUNCTION OF THE PVN IN HEART FAILURE--ROLE OF NITRIC OXIDE AND GABA$153,201
P01 · FY2000 · HL